Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
-
▾0.00 (0.00%)
Last trade: 21/12, 1:14PM
Market cap
-
Market closed
Talk to Sirtex Medical Limited directly.
Sign up to their Investor Hub for direct access to the Sirtex Medical Limited team, ask them questions, and see personal updates.
Sirtex Medical Limited has been removed from the Australian Securities Exchange official list as of 24/09/2018
Investor Presentations
Principal Activity
Sirtex Medical Limited (SRX) is a biotechnology and medical device group whose primary objective is to provide effective liver cancer treatments utilising small particle technology to approved markets in Asia Pacific, Americas, Europe, Middle East and Africa (EMEA). SRX's key product is SIR-Spheres microspheres, the treatment for liver cancer.
Address
Level 33/101 Miller St, North Sydney NSW 2060, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
-
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.